Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...

Bright Futures Wealth Management LLC. cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 55.1% in the 4th ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price ...

Blue Trust Inc. lifted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 28.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. Furthermore, revenue ...

Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

From what we can see, insiders were net sellers in Johnson & Johnson's ( NYSE:JNJ ) during the past 12 months. That ...

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.